R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

This week in clinical trials: 2nd-5th January 2024

Despite the multiple challenges that faced clinical trials in 2023, according to GlobalData’s Pharmaceutical Intelligence Centre, some 22,338

R&D

The problems of animal research for human medicine and the a...

The Oxford Centre for Animal Ethics is an independent centre pioneering ethical perspectives on animals and putting them on the intellectual agenda.

R&D

Why amplifying the patient voice is crucial to clinical tria...

Participants are vital to the success of any clinical trial. Without the data they provide, our research system would collapse. But being a clinical trial participant is not easy.

R&D

The race for obesity drug assets heats up

The existing treatments for weight loss have drawn interest from across the industry, as their efficacy and sales potential become evident.

R&D

Scope for action: How the life sciences industry can make pr...

With the next global climate conference, COP28 in Dubai, having begun on 30th November, many businesses have been taking stock of their own record.

R&D

The smart-design evolution of the laboratory space

In this penultimate instalment of the five-part, festive series of the pharmaphorum podcast, host Nicole Raleigh speaks with Bobby Savarese, senior principal and business development direct